We have located links that may give you full text access.
COMPARATIVE STUDY
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Aqueous formation of hydroxyapatite.
Journal of Biomedical Materials Research 1997 June 6
The kinetics of stoichiometric (Ca/P = 1.67) and calcium-deficient (Ca/P = 1.5) hydroxyapatite formed in aqueous solution by acid-base reactions involving CaHPO4 and Ca4(PO4)2O were determined. Complete reaction occurs within 6 h at 37.4 degrees C regardless of composition with stoichiometric hydroxyapatite forming more rapidly. Stoichiometric hydroxyapatite formed more rapidly because the particle sizes of its precursors were smaller. Hydroxyapatite formation is characterized by an initial period of surface hydration of the precursors, an induction period, and a period during which the bulk of the conversion to hydroxyapatite occurs. During the first 3 h of reaction at 37.4 degrees C, the pH is about 8.25 and 7.6, respectively, as the stoichiometric and calcium-deficient hydroxyapatite are being formed. Subsequently the pH values move toward those of the related invariant points: Ca10(PO4)6(OH)2-Ca(OH)2 solution, and CaHPO4-Ca9HPO4(PO4)5OH solution. The concentrations of calcium and phosphate in solution never exceed those in serum. Seeding with 5 wt% hydroxyapatite eliminates induction regardless of composition. The kinetics are first-order and follow the Arrhenius relationship regardless of composition. The total heats of reaction (delta Hr) were determined at constant temperatures between 25 degrees C and 70 degrees C. delta Hr values of 261.3 and 320 kJ/mol were determined for the formation of calcium-deficient hydroxyapatite and stoichiometric hydroxyapatite, respectively. Activation energies of 84.5 and 87.4 kJ/mol were calculated for the formation of calcium-deficient and stoichiometric hydroxyapatite, respectively. Heats of formation for Ca4(PO4)2O and Ca9HPO4(PO4)5OH were calculated to be -4764.1 and -12707.7 kJ/mol, respectively.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond.Journal of Clinical Medicine 2024 Februrary 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app